Literature DB >> 1848288

'Neuroendocrine' differentiation in primary neoplasms of the liver.

J H Wang1, A P Dhillon, E A Sankey, A K Wightman, J F Lewin, P J Scheuer.   

Abstract

Thirty primary liver neoplasms (16 hepatocellular, nine biliary, and five epithelioid haemangioendotheliomas) were studied for the expression of the general 'neuroendocrine' markers, neurone specific enolase (NSE) and protein gene product 9.5 (PGP 9.5). Grimelius silver staining for neurosecretory granules and immunostaining for S100 protein, HMB-45, vasoactive intestinal polypeptide (VIP), and calcitonin were also performed. Eleven of the 16 hepatocellular carcinomas stained positively for PGP 9.5, four for NSE, six for HMB-45, and two for S100 protein. Seven exhibited granular staining by the Grimelius method; eight showed immunostaining for VIP, and two for calcitonin. Three of the five haemangioendotheliomas demonstrated positive immunostaining for PGP 9.5, and two for NSE; of the nine biliary carcinomas, two showed staining for PGP 9.5 and NSE, and four contained cells staining with the Grimelius technique. Primary neoplasms of liver may show 'neuroendocrine' differentiation and this aspect of their phenotypic expression has to be considered before predicting the site of origin of a tumour in the liver.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848288     DOI: 10.1002/path.1711630111

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  The stem cells of the liver--a selective review.

Authors:  K Aterman
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas.

Authors:  T Terada; Y Kitamura; T Ohta; Y Nakanuma
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

3.  Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.

Authors:  Monica T Garcia; Pablo A Bejarano; Maria Yssa; Efren Buitrago; Alan Livingstone
Journal:  Virchows Arch       Date:  2006-08-01       Impact factor: 4.064

4.  Genomic analysis of fibrolamellar hepatocellular carcinoma.

Authors:  Lei Xu; Florette K Hazard; Anne-Flore Zmoos; Nadine Jahchan; Hassan Chaib; Phillip M Garfin; Arun Rangaswami; Michael P Snyder; Julien Sage
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

5.  Liver Metastases of Neuroendocrine Tumors Rarely Show Overlapping Immunoprofile with Hepatocellular Carcinomas.

Authors:  Ming Jin; Xiaoping Zhou; Martha Yearsley; Wendy L Frankel
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

6.  Melanoma-associated antigens in tumours of the nervous system: an immunohistochemical study with the monoclonal antibody HMB-45.

Authors:  C Zimmer; J Gottschalk; S Goebel; J Cervos-Navarro
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 7.  Angiomyolipoma of the liver: a collective review.

Authors:  A Nonomura; Y Mizukami; M Kadoya
Journal:  J Gastroenterol       Date:  1994-02       Impact factor: 7.527

8.  Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas.

Authors:  Aping Yuan; Jinzhong Liu; Yiqing Liu; Guanglin Cui
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

9.  Atrial myxoma: a tumour in search of its origins.

Authors:  D M Krikler; J Rode; M J Davies; N Woolf; E Moss
Journal:  Br Heart J       Date:  1992-01

10.  Elevated serum levels of Chromogranin A in hepatocellular carcinoma.

Authors:  Antonio Biondi; Giulia Malaguarnera; Marco Vacante; Massimiliano Berretta; Velia D'Agata; Michele Malaguarnera; Francesco Basile; Filippo Drago; Gaetano Bertino
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.